Revive Therapeutics plummets 10.7% on firm volume February 03, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
Revive Therapeutics Ltd. (TSXV:RVV), Canada's 46th largest Biotechnology company by market cap, has plummeted 1.50c (10.7%) from its last trading session of February 02 to close at 12.50c. Compared with the S&P/TSX 60 Index which rose 4.9 points (0.5%) in the day, the relative price change was -11.2%. The fall was exacerbated by firm volume of 1.1 times the average daily volume of 99,233 shares.
REVIVE THERAPEUTICS BEARISH SIGNALS